Cited by 67Photodynamic Therapy Research StudiesCell death mechanisms and regulationRedox biology and oxidative stress

Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model

Open access
Bhowmick, Reshma, Girotti, Albert W.·2014·Cancer Letters

Abstract

We discovered recently that human breast cancer cells subjected to photodynamic therapy (PDT)-like oxidative stress localized in mitochondria rapidly upregulated nitric oxide synthase-2 (NOS2) and nitric oxide (NO), which increased resistance to apoptotic photokilling. In this study, we asked whether human prostate cancer PC-3 cells would exploit NOS2/NO similarly and, if so, how proliferation of surviving cells might be affected. Irradiation of photosensitized PC-3 cells resulted in a rapid (<1 h), robust (~12-fold), and prolonged (∼20 h) post-irradiation upregulation of NOS2. Caspase-3/7 activation and apoptosis were stimulated by NOS2 inhibitors and a NO scavenger, implying that induced NO was acting cytoprotectively. Cyclic GMP involvement was ruled out, whereas suppression of pro-apoptotic JNK and p38 MAPK activation was clearly implicated. Cells surviving photostress grew back ~2-times faster than controls. NOS2 inhibition prevented this and the large increase in cell cycle S-phase occupancy observed after irradiation. Thus, photostress upregulation of NOS/NO elicited both a pro-survival and pro-growth response, both of which could compromise clinical PDT efficacy unless suppressed, e.g. by pharmacological intervention with a NOS2 inhibitor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.canlet.2013.09.025

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Increased NO production after low doses of ALA-PDT with less than ~25% cell killing not only prevented tumor cell death but also made surviving tumor cells more proliferative and migratory.

    “Such increased NO production, which occurred after low doses of ALA-PDT with less than ~25% cell killing, not only prevented tumor cell death but also made surviving tumor cells more proliferative and migratory [144,145,146].”

    From 5-Aminolevulinic Acid as a Theranostic Agent for Tumor Fluorescence Imaging and Photodynamic Therapy (2023) · cites this paper as [144]

    Results §3.3 reports that ALA/light-stressed PC-3 cells induced NOS2 and NO, which protected them against apoptotic death; Results §3.6 reports faster NO-dependent growth among surviving cells. The paper does not report increased migration or establish the claimed threshold of less than ~25% cell killing. Its ~25% figure in §3.6 describes growth in an inhibitor-treated group, not cell killing. (LLM, conf=0.87)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 48 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [26]Siegert A Rosenberg C Schmitt WD Denkert C Hauptmann S Nitric oxide of human colorectal adenocarcinoma cell lines promotes tumor cell invasion Br. J. Cancer 2002 86 1310 1315 11953890 PMC2375351

Cited by

Sorted by citations

Authors
Bhowmick, R., & Girotti, A. W.
Affiliations
Medical College of Wisconsin (US)
Corresponding author
  • Bhowmick, Reshma
  • Girotti, Albert W.
Venue
Cancer Letters
Publisher
Elsevier BV
Published
2014-02
Volume
343
Issue
1
Pages
115-122
ISSN
0304-3835 (ISSN-L)
OpenAlex
W2126780194
Cited by
65
References
48
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 8 · 2021: 3 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 5 · 2016: 8 · 2015: 8 · 2014: 5
FWCI
5.19
Type
journal article
Language
en
Open access
Locations
  • Cancer Letters (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Cancer Institute (CA70823, R01CA070823)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Photodynamic Therapy Research Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
Keywords
photodynamic therapy, nitric oxide, nitric oxide synthase 2, prostate cancer, PC-3 cells, oxidative stress, apoptosis resistance, cell survival, cell proliferation, JNK, p38 MAPK, S phase arrest, photosensitizers
MeSH terms
Cell Cycle, Cell Survival, Enzyme Activation, Free Radicals, Humans, Light, Male, Nitric Oxide, Photochemotherapy, Prostatic Neoplasms, Apoptosis, MAP Kinase Signaling System, Cell Line, Tumor, Cell Proliferation, Nitric Oxide Synthase Type II, Caspase 3, Caspase 7

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review